Grant Julie Papanek - Insider Non-Derivative Transactions at Day One Biopharmaceuticals, Inc. (DAWN) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 1, 2023, Grant Julie Papanek's relationship to Day One Biopharmaceuticals, Inc. (DAWN) is Director, and currently has 330,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other DAWN insiders.
Data Source: SEC.
Grant Julie Papanek - Insider Non-Derivative Transactions of DAWN Common Stock
Grant Julie Papanek - Insider Non-Derivative Transactions at DAWN
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 2, 2023 | Sell -- (Common Stock) | 25000 | 18.61 | 330000 |
| Feb 2, 2023 | Sell -- (Common Stock) | 1106 | 21.69 | 355000 |
| Feb 2, 2023 | Sell -- (Common Stock) | 23894 | 21.21 | 356106 |
| Jan 4, 2023 | Sell -- (Common Stock) | 7610 | 21.31 | 380000 |
| Jan 4, 2023 | Sell -- (Common Stock) | 17390 | 20.36 | 387610 |